mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |